Venetoclax may become the best Treatment for Patients who are intolerant to Ibrutinib - 101931

Spotlight
Video

Venetoclax may become the best Treatment for Patients who are intolerant to Ibrutinib

ASHReport has 317 videos Subscribe Here

Loading........
Description: Brian Hill, MD, PhD, of Cleveland Clinic discusses how Venetoclax may be the best novel agent for patients who are intolerant to Ibrutinib at the 58th ASH Annual Meeting in San Diego, CA.
Shared By : ASHReport
Posted on : 12/13/16
Added : 3 years ago